SaniSure, a global developer and manufacturer of single-use technology for the biopharmaceutical industry, announced today it has acquired GL Engineering (GLE) of East Hanover, New Jersey.
Biotech Cleanroom Industry Articles
Taiyo Pharma Tech to Establish Gene Therapy Manufacturing Using Cytiva’s FlexFactory™ Solution
Cytiva’s FlexFactory is a one-stop solution for equipment and services following single-use technology and a modular design tailored to the manufacturer’s needs.
AllCells Announces New GMP Cleanroom
AllCells, the industry leader in the procurement and customization of human-derived hematological tissues and services, is pleased to announce the expansion of its flagship processing facility in Alameda, California.
Nanotech Powered Mass Testing Now the Key to Unlocking COVID-19 Lockdowns
The World Nano Foundation and pandemic experts say regular use of inexpensive lateral flow rapid antigen mass testing kits is the way to beat COVID-19, its variants and future viruses.
Heska Corporation to Acquire Lacuna Diagnostics, a Pioneer and Market Leader in Point-of-Care Digital Cytology
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty products, announced today that the Company has entered into an agreement (the “Agreement”) to acquire 100% of Lacuna Diagnostics, Inc. (“Lacuna”), a pioneer and market leader in point-of-care diagnostics digital cytology technology and telemedicine services.
AirBox Air Purifier Scientifically Proven to Remove >99.99% of Airborne Pathogens, Including MS2 Bacteriophage, a SARS-Cov-2 (COVID-19) Representative Virus
At a time when a clean and safe air environment is of paramount importance for school systems and businesses, certified HEPA AirBox Air Purifier Peak Series-S has been scientifically proven by independent lab testing company Microchem Laboratory to filter 99.99% of MS2 Bacteriophage, a SARS-Cov-2 (COVID-19) representative virus, and three other common pathogens in just 25 minutes, achieving a 4 log reduction of particulates.
Prime Minister announces £20m to grow medicines manufacturing in the UK
The Prime Minister will launch the government’s new capital investment fund, the Medicines and Diagnostic Manufacturing Transformation Fund, while visiting North Wales later today. This will open up investment opportunities for medicines manufacturers in England, Scotland and Wales – improving our domestic medicine supply chains and creating thousands of highly skilled jobs in the process.
Purolite Announces Expansion to Address the High-demand for Pharmaceutical Products
Purolite Corporation is expanding its manufacturing capabilities to address and fulfill the increasing global demand for its pharmaceutical and life science products. The new facility will include two new cleanrooms to manufacture active pharmaceutical ingredients (APIs) and excipients and an agarose manufacturing facility equipped with proprietary jetting technology for the capture and purification of (mAbs) monoclonal antibodies sold under the Praesto® brand.
SteriPack Group announces global rollout of sterile swabs to help combat Covid-19
SteriPack Group rapidly deploys equipment, expertise and facilities to meet critical need for sterile swabs, diagnostic products and personal protective equipment across their global manufacturing network.
ALK Life Science Solutions and UPPI Announce Partnership to Provide High-Quality Vials for Improved Patient Care
ALK Life Science Solutions, a business unit of ALK-Abelló, Inc. (ALK), serving the North American pharmaceutical packaging-based market for glass vials, and UPPI, LLC, the largest association of independent and university-based nuclear pharmacies serving the diagnostic imaging community in the U.S., announced today that they have entered into a three-year partnership to provide high-quality glass vials to UPPI members providing unit dose radiopharmaceuticals and positron emission tomography (PET) manufacturing of radiopharmaceuticals for use in nuclear imaging tests and treatments.
Johns Hopkins Reports Promising Clinical Data in COVID-19 ARDS Treated with Cellenkos’ Cord Blood T-Regulatory Cells
Physician-investigators at Johns Hopkins University Hospital report on the promising data of treatment of COVID-19 induced acute respiratory distress syndrome with allogeneic, cord blood derived T-regulatory (Treg) cell therapy (manufactured by Cellenkos®), published in peer reviewed journal of Annals of Internal Medicine.
Grand River Aseptic Manufacturing Opens Large-Scale Injectable Fill/Finish Facility, Significantly Increasing Capacity
Grand River Aseptic Manufacturing (“GRAM”), an agile and modern parenteral contract development and manufacturing organization (CDMO), completed its major $60 million expansion project and recently took occupancy.